課程資訊
課程名稱
癌症標靶治療標誌開發特論一
Current Topics on Biomarker Assessment For Cancer Target Therapy(Ⅰ) 
開課學期
106-1 
授課對象
醫學院  醫學檢驗暨生物技術學研究所  
授課教師
胡忠怡 
課號
CliLab8009 
課程識別碼
424 D5010 
班次
 
學分
2.0 
全/半年
半年 
必/選修
選修 
上課時間
星期一6,7(13:20~15:10) 
上課地點
第十講堂 
備註
初選不開放。與林亮音、郭遠燁、歐大諒合授
總人數上限:15人 
Ceiba 課程網頁
http://ceiba.ntu.edu.tw/1061CliLab8009_ 
課程簡介影片
 
核心能力關聯
核心能力與課程規劃關聯圖
課程大綱
為確保您我的權利,請尊重智慧財產權及不得非法影印
課程概述

自2003人類基因解碼之後,疾病的分子機轉接連的被探討,矢的標靶治療的研究與開發成為21世紀癌症治療的契機;尤其,血液疾病的探討更是其中的領導者.本課程主要以血液疾病分子機轉為主題,自頂尖雜誌中選取相關文章作深入的探討. 

課程目標
待補 
課程要求
待補 
預期每週課後學習時數
 
Office Hours
 
指定閱讀
待補 
參考書目
待補 
評量方式
(僅供參考)
   
課程進度
週次
日期
單元主題
第1週
9/11  迎新學術研討會,停課一次 
第2週
9/18  A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. Cancer Research(2017), 77(16):4402(傅宇暄)
The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells. Blood Cancer Journal . 2017 Feb; 7(2): e527 (羅芳妤) 
第3週
9/25  Clonal fate mapping quantifies the number of haematopoietic stem cells that arise during development(黃焱)
MicroRNA-206 acts as a tumor suppressor in bladder cancer via targeting YRDC. American Journal of Translational Research, 2016; 8(11):4705-4715(高亦欣) 
第4週
10/02  Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy.
Blood 2016 128:253-264(呂文惠)
Enhanced Fructose Utilization Mediated by SLC2A5 Is a Unique Metabolic Feature of Acute Myeloid Leukemia with Therapeutic Potential. Cancer Cell. 2016 Nov 14;30(5):779-791(吳潔雯)
 
第5週
10/09  調整放假 
第6週
10/16  A Bak-dependent mitochondrial amplification step contributes to Smac mimetic /glucocorticoid-induced necroptosis
Cell Death and Differentiation 2017;24:83–97(周映辰)
LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis
Cancer Cell 2017; 32: 310–323(王克巍)
 
第7週
10/23  The role of ZAP70 kinase in acute
lymphoblastic leukemia infiltration into the central nervous system.(陳怡臻)
The Role of the Gastrointestinal Microbiome in Infectious Complications During Induction Chemotherapy for Acute Myeloid Leukemia(劉育安) 
第8週
10/30  Genetic deletion or small-molecule inhibition of the arginine methyltransferase PRMT5 exhibit anti-tumoral activity in mouse models of MLL-rearranged AML(羅芳妤)
Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion. (傅宇暄)
 
第9週
11/06  Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia.(呂文惠)
High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells. (吳潔雯)
 
第10週
11/13  A non-coding function of TYRP1 mRNA promotes melanoma growth. (高亦欣)
The TCA cycle transferase DLST is important for MYC-mediated leukemogenesis. (陳怡臻)
 
第11週
11/20  Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia. (周映辰)

Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression.(王克巍)